# A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye

> **NCT07068958** · PHASE2 · NOT_YET_RECRUITING · sponsor: **ORA, Inc.** · enrollment: 200 (estimated)

## Conditions studied

- Dry Eye Disease (DED)

## Interventions

- **DRUG:** 0.25% RCI001 Ophthalmic Solution
- **DRUG:** Placebo Ophthalmic Solution (vehicle)

## Key facts

- **NCT ID:** NCT07068958
- **Lead sponsor:** ORA, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2025-11-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07068958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07068958, "A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07068958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*